Bottom line
What does FBT hold?
FBT held 32 positions as of Jun 30, 2026. Its largest holding is Corcept Therapeutics Inc at 5.60% of the fund, and the top 10 positions add up to 43.2%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Aug 21, 2026
FBT top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Corcept Therapeutics Inc CORT CORCEPT THERAPEUTICS INC COM |
Stocks | 5.60% | $157.5M |
| 2 | Neogenomics Inc NEO NEOGENOMICS INC COM NEW |
Stocks | 5.12% | $144.0M |
| 3 | Veracyte Inc VCYT VERACYTE INC COM |
Stocks | 5.10% | $143.4M |
| 4 | Bruker Corp BRKR BRUKER CORP COM |
Stocks | 4.32% | $121.5M |
| 5 | Alkermes Plc ALKS ALKERMES PLC SHS |
Stocks | 4.24% | $119.2M |
| 6 | Illumina Inc ILMN ILLUMINA INC COM |
Stocks | 3.92% | $110.4M |
| 7 | Krystal Biotech Inc KRYS KRYSTAL BIOTECH INC COM |
Stocks | 3.87% | $108.9M |
| 8 | Natera Inc NTRA NATERA INC COM |
Stocks | 3.79% | $106.7M |
| 9 | Axsome Therapeutics Inc AXSM AXSOME THERAPEUTICS INC COM |
Stocks | 3.71% | $104.3M |
| 10 | Neurocrine Biosciences Inc NBIX NEUROCRINE BIOSCIENCES INC COM |
Stocks | 3.53% | $99.2M |
| 11 | Bio-techne Corp TECH BIO-TECHNE CORP COM |
Stocks | 3.43% | $96.5M |
| 12 | Arrowhead Pharmaceuticals Inc ARWR ARROWHEAD PHARMACEUTICALS INC COM |
Stocks | 3.38% | $95.0M |
| 13 | Biogen Inc BIIB BIOGEN INC COM |
Stocks | 3.37% | $94.8M |
| 14 | Exelixis Inc EXEL EXELIXIS INC COM |
Stocks | 3.32% | $93.3M |
| 15 | Incyte Corp INCY INCYTE CORP COM |
Stocks | 3.18% | $89.6M |
| 16 | Argenx Se ARGX ARGENX SE SPONSORED ADR |
Stocks | 3.13% | $88.1M |
| 17 | Halozyme Therapeutics Inc HALO HALOZYME THERAPEUTICS INC COM |
Stocks | 3.11% | $87.6M |
| 18 | Vertex Pharmaceuticals Inc VRTX VERTEX PHARMACEUTICALS INC COM |
Stocks | 3.07% | $86.4M |
| 19 | Repligen Corp RGEN REPLIGEN CORP COM |
Stocks | 3.07% | $86.2M |
| 20 | Biomarin Pharmaceutical Inc BMRN BIOMARIN PHARMACEUTICAL INC COM |
Stocks | 2.83% | $79.6M |
| 21 | Amgen Inc AMGN AMGEN INC COM |
Stocks | 2.78% | $78.3M |
| 22 | Biontech Se BNTX BIONTECH SE SPONSORED ADS |
Stocks | 2.63% | $73.9M |
| 23 | Genmab A/s GMAB GENMAB A/S SPONSORED ADS |
Stocks | 2.62% | $73.8M |
| 24 | United Therapeutics Corp UTHR UNITED THERAPEUTICS CORP COM |
Stocks | 2.56% | $71.9M |
| 25 | Alnylam Pharmaceuticals Inc ALNY ALNYLAM PHARMACEUTICALS INC COM |
Stocks | 2.52% | $70.9M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 21, 2026